[1]
“EVALUATION OF THE PRESCRIPTION PATTERNS OF ANTITUBERCULAR DRUGS AND ASSESSMENT OF DRUG UTILIZATION USING WHO CORE PRESCRIBING INDICATORS”, Int. Res. J. Pharm., vol. 17, no. 9, pp. 1–10, Sep. 2026, doi: 10.56802/k8x24732.